Epidemiology of postcovid complications
Article Sidebar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Main Article Content
Abstract
Coronavirus infection of 2019 (COVID-19) is caused by the novel coronavirus of severe acute respiratory syndrome 2 (SARS-CoV-2) and has rapidly turned into a global pandemic. Long COVID-19 and post-COVID complications remain a relevant health problem, causing a wide range of symptoms that persist after the acute phase of SARS- CoV-2 infection. This review systematizes the current data on the epidemiology of post- COVID syndrome and risk factors for its development. Demographic and clinical characteristics, including age, gender, comorbidities, severity of COVID-19, and socioeconomic conditions that increase the likelihood of long-term complications, are discussed. Data on the prevalence of post-COVID symptoms in various population groups and their impact on quality of life are presented.
Article Details
References
Suvvari, T. K., Kutikuppala, L. V. S., Tsagkaris, C.,
Corriero, A. C., & Kandi, V. (2021, December). Post-COVID-19 complications: Multisystemic approach. Journal of Medical Virology, 93(12), 6451–6455. https://doi.org/10.1002/jmv.27222
Vos, T., et al. (2022). Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA, 328, 1604–1615. https://doi.org/10.1001/jama.2022.17516
Alimohamadi, Y., Sepandi, M., Taghdir, M., & Hosamirudsari, H. (2020). Determine the most common clinical symptoms in COVID-19 patients: A systematic review and meta- analysis. Journal of Preventive Medicine and Hygiene, 61(3), E304–E312. https://doi.org/10.15167/2421-4248/jp mh2020.61.3.1530
Aiyegbusi, O. L., Hughes, S. E., Turner, G., et al. (2021). Symptoms, complications and management of long COVID: A review. Journal of the Royal Society of Medicine, 114(9), 428–442. https://doi.org/10.1177/01410768211032850
Centers for Disease Control and Prevention. (2025, August 10). About long COVID: Long COVID basics. https://www.cdc.gov/long-covid/about/index.html
Gu, L., Yue, J., Lin, J., Liu, Z., & Huang, J.-A. (2025). Challenges in diagnosis and treatment of long COVID. Frontiers in Medicine, 12, 1641411. https://doi.org/10.3389/fmed.2025.1641411
43rd World Health Assembly. (n.d.). International statistical classification of diseases and related health problems, 10th revision (online version). https://mkb10.com/index.php?p=id=23014
Au, L., Capotescu, C., Eyal, G., & Finestone, G. (2022). Long COVID and medical gaslighting: Dismissal, delayed diagnosis, and deferred treatment. SSM Qualitative Research in Health, 2, 100167. https://doi.org/10.1016/j.ssmqr.2022.100167
Greenhalgh, T., Sivan, M., Perlowski, A., & Nikolich, J. Z. (2024). Long COVID: Aclinical update. Lancet, 404, 707–724. https://doi.org/10.1016/S0140-6736(24)01136-X
Raman, B., Bluemke, D. A., Lüscher, T. F., et al. (2022, March 14). Long COVID: Post- acute sequelae of COVID-19 with a cardiovascular focus. European Heart Journal,43(11), 1157–1172. https://doi.org/10.1093/eurheartj/ehac031
Sisodia, R. C., Dankers, C., Orav, J., Joseph, B., Meyers, P.,
Wright, P., St Amand, D., Del Carmen, M., Ferris, T., Heng, M., Licurse, A., Meyer, G., & Sequist, T. D. (2020, April1). Factors associated with increased collection of patient-reported outcomes within a large health care system. JAMA Network Open, 3(4), e202764. https://doi.org/10.1001/jamanetworkopen.2020.2764
Luo, S., Lai, L. Y., Zhu, R., Gao, Y., & Zhao, Z. (2025, October 17). Prevalence and duration of common symptoms in people with long COVID: A systematic review and meta- analysis. Journal of Global Health, 15, 04282. https://doi.org/10.7189/jogh.15.04282
Demko, Z. O., Yu, T., Mullapudi, S. K., Varela Heslin, M. G.,
Dorsey, C. A., Payton, C. B., ... & Antar, A. A. R. (2024, March 6). Two-year longitudinal study reveals that long COVID symptoms peak and quality of life nadirs at 6–12 months postinfection. Open Forum Infectious Diseases, 11(3), ofae027. https://doi.org/10.1093/ofid/ofae027
Tsampasian, V., et al. (2023). Risk factors associated with post-COVID-19 condition: A systematic review and meta-analysis. JAMA Internal Medicine, 183(6), 566–580. https://doi.org/10.1001/jamainternmed.2023.0921
Swift, K., et al. (2022, January). Risk factors and disease profile of post- vaccinationSARS- CoV-2 infection. Lancet Infectious Diseases, 22(1), 43– 55.https://doi.org/10.1016/S1473- 3099(21)00489-0
Centers for Disease Control and Prevention. (2025, February 6). Underlying conditions and the higher risk for severe COVID‑19. https://www.cdc.gov
Alonso-Bello, C. D., Pérez-Barragán, E., Moncayo-Coello, C. V., & Rojo-Gutiérrez, M. I. (2024). COVID-19 in the post-vaccination era: Who is at risk of severe disease? Allergy& Infectious Disease, 5(1), 6–8. https://doi.org/10.46439/allergy .5.040
Sannigrahi, S., Pilla, F., Basu, B., Basu, A. S., & Molter, A. (2020). Examining the association between socio-demographic composition and COVID-19 fatalities in the European region using spatial regression approach. Sustainable Cities and Society, 62, 102418. https://doi.org/10.1016/j.scs.2020.102418
Jaljaa, A., Caminada, S., Tosti, M. E., D’Angelo, F., Angelozzi, A., Isonne, C., ... & Marceca, M. (2022). Risk of SARS-CoV-2 infection in migrants and ethnic minorities compared with the general population in the European WHO region during the first year of the pandemic: A systematic review. BMC Public Health, 22, 143. https://doi.org/10.1186/s12889-021-12466-1
Sudre, C. J., et al. (2021). Attributes and predictors of long COVID. Nature Medicine. https://doi.org/10.1038/s41591-021-01292-y
Davis, H. E., et al. (2023). Long COVID: Major findings, mechanisms and recommendations. Nature Reviews Microbiology, 21(3), 133–146.
Mkoma, G. F., Goldschmidt, M. I., Petersen, J. H., Benfield, T., Cederström, A., Rostila, M., ... & Norredam, M. (2025, May). Socioeconomic disparities in long COVIDdiagnosis among ethnic minorities in Denmark. Social Science & Medicine, 372, 117944. https://doi.org/10.1016/j.socscimed.2025.117944
Office for National Statistics. (2020). The prevalence of long COVID symptoms and COVID-19complications. https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandc ovid19complications
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V.,
McGroder, C., Stevens, J. S., et al. (2021). Post-acute COVID-19 syndrome. Nature Medicine, 27, 601–615. https://doi.org/10.1038/s41591-021-01283-z
Taquet, M., Geddes, J. R., Husain, M., Luciano, S., &
Harrison, P. J. (2021). Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLOS Medicine, 18, e1003773. https://doi.org/10.1371/journal.pmed.1003773
Subramanian, A., Nirantharakumar, K., Hughes, S., Myles, P., Williams, T., Gokhale, K. M., ... & Lord, J. M. (2022, August). Symptoms and risk factors for long COVID in non- hospitalized adults. Nature Medicine, 28(8), 1706–1714. https://doi.org/10.1038/s41591-022-01909-w
Wang, H.-I., et al. (2024). [Article title]. Journal of Infection. Advance online publication. https://doi.org/10.1016/j.jinf.2024.106235
Kim, D. A nationwide study of risk factors for long COVID and its economic and mental health consequences in the United States. Commun Med 5, 104 (2025). https://doi.org/10.1038/s43856-025-00759-0